The FDA has approved Johnson & Johnson’s (J&J) Spravato (esketamine) CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD). According to ...

Moderna will receive some $590 million from the U.S. government to develop messenger RNA vaccines for influenza strains, such as H5N1, that are seen as potential pandemic risks. Announced Friday as ...

But Datroway’s results come up short compared with Enhertu. The Citeline report also noted one treatment-related death in the Datroway trial. Given that patients with advanced breast cancer have ...

Enhertu. The approval is the first in the U.S. for Datroway, which got clearance in Japan last month. Astra and Daiichi withdrew an application in the European Union for the drug to treat a type ...

Treatment with durvalumab (Imfinzi) did not improve outcomes over cetuximab (Erbitux) when given to patients with locoregionally advanced head and neck squamous cell carcinoma (HNSCC) undergoing ...

Enhertu is already approved as a third-line therapy for HER2-positive metastatic breast cancer and a second-line therapy for HER2-positive metastatic gastric cancer, and recent data from the ...

Enhertu is already approved as a third-line therapy for HER2-positive breast cancer, but moving the drug up the treatment pathway could make it an option for a larger group of patients and ...